ADIPOQ and chronic obstructive pulmonary disease: On the other hand, Kirdar et al. [78] reported that the presence of a high level of adiponectin could be an attempt to reduce pro-inflammatory cytokines in chronic obstructive pulmonary disease, leading to a downregulation of TNF-α production by macrophages at the bronchio-alveolar epithelium.